BEIJING, Dec. 25 (China Economic Net) - Guangdong Shuanglin Bio-pharmacy Co., Ltd., a subsidiary of PLBIO, has secured regulatory approval from Pakistan for its Intravenous Immunoglobulin (pH4), a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback